Peptide

99.9% Purity COA Testing Report Mazdutide/Cagrilintide/Retatrutide Lyophilized Powder CAS 2381089-83-2 Weight Loss Peptide Research Reagents

99.9% Purity COA Testing Report Mazdutide/Cagrilintide/Retatrutide Lyophilized Powder CAS 2381089-83-2 Weight Loss Peptide Research Reagents

Style number	OC-005
Product name:	Mazdutide (IBI362)
CAS:	Not publicly assigned
Molecular Formula:	Peptide-based (available upon request)
Certification:	GMP, ISO 9001, USP, BP
State:	White to off-white powder
Specification:	2mg 10mg 15mg 20mg 25 mg 50mg
Origin:	China
Suitable for:	Elderly, Children, Adult
Purity:	≥98% (HPLC)
Grade:	Pharmaceutical / Research use
Transport Package:	Box, According to Your Need

Description
Related Products

Mazdutide (also known as IBI362) is an innovative dual agonist targeting GLP-1 and glucagon receptors, developed for the treatment of obesity, type 2 diabetes, and related metabolic disorders. As a new-generation peptide drug, Mazdutide offers a powerful combination of weight reduction, glycemic control, and lipid regulation in one formulation.

Key Advantages:

Dual Mechanism of Action: Simultaneously activates GLP-1 and glucagon receptors to enhance metabolic effects.
Effective Weight Loss: Promotes satiety and increases energy expenditure, aiding in long-term weight control.
Improved Glucose & Lipid Metabolism: Demonstrated benefits in lowering blood sugar and improving lipid profiles.
Once-Weekly Dosing: Designed for convenient and sustained therapeutic effect with fewer injections.